Sponsorizzato
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
Posted
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns with the company's expectation that 50% of its revenue will come from the U.S. by 2030. The decision comes amid rising tariff pressures from the Trump administration, aiming to bolster domestic drug supply chains.
Cerca
Categorie
- National
- International
- Business
- Technology
- Health
- Formazione
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leggi tutto
Richa recalls how her Nani warned her about marriage
Richa Chadha recounted a childhood experience where her grandmother's words reflected the gender...
'Weak attempt at distraction': Obama offers rare rebuke on Trump’s ‘treason’ claims; Democrats call it Epstein diversion
Former President Obama's office refuted Trump's accusations of "treason" and election...
United States bans transgender from women's events, citing Trump order
Following President Trump's executive order, the USOPC has banned transgender women from...
Economic Digest: Nepal’s Business News in a Snap
KATHMANDU: Economic Digest offers a concise yet comprehensive overview of significant business...